Interferon therapy in hepatitis C leading to chronic type 1 diabetes - Wikidata - wikimedia - TriplyDB

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

http://www.wikidata.org/entity/Q28080876

about

Hepatitis C and insulin action: An intimate relationship Aptamers in diagnostics and treatment of viral infections Viral infections in type 1 diabetes mellitus--why the β cells?A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases Oligonucleotide aptamers: potential novel molecules against viral hepatitis.Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas.

P2860

Q26775000-D4FAE164-5998-45DC-9B8C-78B20DBAB28A Q27014527-89C7CE44-1918-44C6-BBB9-88C79EE4A8D5 Q37697741-6BB4A406-97A3-45C4-A31F-314DD008D0F6 Q37703437-C4E4CAB6-E4A0-4E79-831D-520BD0AB9C2B Q37743634-7CAF9E14-F4AB-4497-A2C7-51080DB7BA62 Q38872318-7A889E5D-2FC7-4D7C-BC2C-9534D1A64873 Q39405656-02FD03F7-E186-468A-B37C-1500909D38F3

P2860

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

http://www.wikidata.org/entity/Q28080876

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@ast

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@en

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@nl

type

label

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@ast

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@en

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@nl

prefLabel

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@ast

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@en

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@nl

P1433

Q28080876-FD7E3B6C-DDB1-4DAB-A103-34AA05AF2405

P1476

Q28080876-708BC588-6DA9-4847-AB4B-21034357E350

P2093

Q28080876-0FECAE23-0F4A-4D41-9FEF-0C046722E28E

P2860

Q28080876-0C23201C-0D1B-432E-A348-585EE6A3CED7

Q28080876-130404F5-2A0F-4CB5-BB18-C16EC32AB9D6

Q28080876-14DE24C3-6FEE-41F3-97F7-81CF01ED0469

Q28080876-1C2DA816-CFF3-4697-ACF5-DBD8F28E9679

Q28080876-22149291-1793-4368-A121-675888ED17D7

Q28080876-30F07517-EC11-4BF1-8615-8DA32B1AC841

Q28080876-321B44AF-070A-4D3A-BE27-04AA3493A546

Q28080876-32EC3DA8-A174-4DCC-B6F5-3FAAA8F0D40A

Q28080876-348AFFF5-6C1B-4C6A-B0C8-134AEAEC9356

Q28080876-362D1EAB-DB42-4A67-8E38-7DFAC6F72D36

P304

Q28080876-6651F69A-82B4-4BEF-AAB2-DC4C79473FCE

P31

Q28080876-22F8B547-B8F3-490C-BD5E-CF2C9916211B

P356

Q28080876-EFD294A4-AD55-46C2-909A-F567F78A07FD

P407

Q28080876-C72C5B35-EF92-4162-BB0B-27E19C546C05

P433

Q28080876-105D8459-3831-4545-B1A1-2E56993BA5B6

P478

Q28080876-BC97A71D-7533-465E-A084-8B36886A573A

P577

Q28080876-19B473F5-D33E-4290-9603-943B219CD0F1

P5875

Q28080876-ED303C74-82A9-4D42-91DD-176FD713497F

P698

Q28080876-5E37966B-A297-4038-9F1B-303C6262D356

P921

Q28080876-DDC4D869-1A2E-44A4-967C-C4CF8997A9A3

P932

Q28080876-C5F786E4-9CBD-48B6-B1D2-536981E3BBB1

P356

P1433

World Journal of Gastroenterology

P1476

Interferon therapy in hepatitis C leading to chronic type 1 diabetes

@en

P2093

Taiba Zornitzki

http://www.w3.org/2001/XMLSchema#string

P2860

New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.

Association of Raynaud's syndrome with interferons. A meta-analysis.

The hepatitis C virus modulates insulin signaling pathway in vitro promoting insulin resistance

Diabetes mellitus during interferon therapy for chronic viral hepatitis.

Side effects of therapy of hepatitis C and their management.

Pulmonary side effects of interferon-alpha therapy in patients with hematological malignancies.

Type 1 diabetes and interferon therapy: a nationwide survey in Japan.

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.

P304

233-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I1.233

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270657054

http://www.w3.org/2001/XMLSchema#string

P698

25574096

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

4284340

http://www.w3.org/2001/XMLSchema#string